Witternheim, France

Thierry Massfelder



Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thierry Massfelder: Innovator in Renal Cell Carcinoma Treatment

Introduction

Thierry Massfelder is a notable inventor based in Witternheim, France. He has made significant contributions to the field of medical research, particularly in the treatment of renal cell carcinoma. His innovative approach focuses on the use of PTHrP antagonists, which has the potential to change the landscape of cancer treatment.

Latest Patents

Massfelder holds a patent for the "Use of PTHrP antagonists for treating renal cell carcinoma." This invention concerns the application of a PTHrP antagonist in preparing a pharmaceutical composition aimed at treating renal cell carcinoma (RCC) in mammals, especially in human subjects. The invention is particularly valuable for inhibiting or reducing tumor growth and metastasis formation in kidney cancer, with specific implications for metastatic developments in the lung and liver. He has 1 patent to his name.

Career Highlights

Throughout his career, Thierry Massfelder has worked with prestigious institutions such as Université Louis Pasteur and the Institut National de la Santé et de la Recherche Médicale. His work has been instrumental in advancing research in oncology and improving treatment options for patients suffering from kidney cancer.

Collaborations

Massfelder has collaborated with notable colleagues, including Herve Lang and Eric Schordan. Their combined expertise has contributed to the development of innovative solutions in cancer treatment.

Conclusion

Thierry Massfelder's contributions to the field of renal cell carcinoma treatment through his patent on PTHrP antagonists highlight his role as a significant innovator in medical research. His work continues to inspire advancements in cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…